Next Article in Journal
Effects of a Myofascial Technique on the Stiffness and Thickness of the Thoracolumbar Fascia and Lumbar Erector Spinae Muscles in Adults with Chronic Low Back Pain: A Randomized before-and-after Experimental Study
Next Article in Special Issue
Feasibility Study of 3D FACT and IVIM Sequences in the Evaluation of Female Osteoporosis
Previous Article in Journal
Advances in Zebrafish for Diabetes Mellitus with Wound Model
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Amide Proton Transfer-Weighted Imaging Combined with ZOOMit Diffusion Kurtosis Imaging in Predicting Lymph Node Metastasis of Cervical Cancer

1
Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
2
Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins Medical Institutions, Baltimore, MD 21218, USA
*
Author to whom correspondence should be addressed.
Bioengineering 2023, 10(3), 331; https://doi.org/10.3390/bioengineering10030331
Submission received: 19 January 2023 / Revised: 23 February 2023 / Accepted: 2 March 2023 / Published: 6 March 2023
(This article belongs to the Special Issue Advanced Diffusion MRI and Its Clinical Applications)

Abstract

:
Background: The aim of this study is to investigate the feasibility of amide proton transfer-weighted (APTw) imaging combined with ZOOMit diffusion kurtosis imaging (DKI) in predicting lymph node metastasis (LNM) in cervical cancer (CC). Materials and Methods: Sixty-one participants with pathologically confirmed CC were included in this retrospective study. The APTw MRI and ZOOMit diffusion-weighted imaging (DWI) were acquired. The mean values of APTw and DKI parameters including mean kurtosis (MK) and mean diffusivity (MD) of the primary tumors were calculated. The parameters were compared between the LNM and non-LNM groups using the Student’s t-test or Mann–Whitney U test. Binary logistic regression analysis was performed to determine the association between the LNM status and the risk factors. The diagnostic performance of these quantitative parameters and their combinations for predicting the LNM was assessed with receiver operating characteristic (ROC) curve analysis. Results: Patients were divided into the LNM group (n = 17) and the non-LNM group (n = 44). The LNM group presented significantly higher APTw (3.7 ± 1.1% vs. 2.4 ± 1.0%, p < 0.001), MK (1.065 ± 0.185 vs. 0.909 ± 0.189, p = 0.005) and lower MD (0.989 ± 0.195 × 10−3 mm2/s vs. 1.193 ± 0.337 ×10−3 mm2/s, p = 0.035) than the non-LNM group. APTw was an independent predictor (OR = 3.115, p = 0.039) for evaluating the lymph node status through multivariate analysis. The area under the curve (AUC) of APTw (0.807) was higher than those of MK (AUC, 0.715) and MD (AUC, 0.675) for discriminating LNM from non-LNM, but the differences were not significant (all p > 0.05). Moreover, the combination of APTw, MK, and MD yielded the highest AUC (0.864), with the corresponding sensitivity of 76.5% and specificity of 88.6%. Conclusion: APTw and ZOOMit DKI parameters may serve as potential noninvasive biomarkers in predicting LNM of CC.

Graphical Abstract

1. Introduction

Cervical cancer (CC) ranks as the most common gynecologic malignant cancer and one of the leading causes of cancer-specific death in women globally [1]. Lymph node metastasis (LNM) is a major prognostic indicator and an important determinant in treatment options in patients with CC [2]. For patients with early-stage CC (IA, IB1, IB2, and IIA1), radical hysterectomy with lymphadenectomy is commonly recommended [3]. Approximately 8–26% of patients with early stage cancer exhibit pathological LNM and require further postoperative chemo-radiotherapy [4]. If lymph node status is accurately diagnosed, patients can be managed medically, avoiding unnecessary invasive surgery [4].
MRI has been established as the main imaging modality in pre-treatment assessment of LNM in patients with CC [5]. The application of the conventional MRI sequences, which are mainly based on morphologic features, is still challenging due to their low sensitivity (29–69%) for assessing the presence of LNM [6,7]. Diffusion-weighted imaging (DWI) has been successfully introduced as a non-invasive technique to reveal tissue microstructural changes in vivo [8]. ZOOMit DWI applies echo-planar imaging and another parallel radiofrequency pulse sequence to obtain a zoomed field-of-view (FOV) that only covers the region of interest (ROI) and consequently reduces geometric distortion and susceptibility artifacts, which allows for better image quality and more anatomical detail [9]. ADC is a quantitative biomarker that has been widely utilized in oncologic applications. However, no single ADC value has been established as an indicator of lymph node positivity in CC [10]. The non-Gaussian diffusion model—diffusion kurtosis imaging (DKI)—has the potential in quantifying the microstructural heterogeneity of tissues [11,12]. Several previous studies indicated that the DKI-derived parameters were able to estimate the histological features and predict the curative response of CC [13,14,15]. It has been reported that tumors with higher heterogeneity are more prone to lymph node metastasis, suggesting that DKI may be useful in predicting the LNM based on the primary tumors.
Furthermore, chemical exchange saturation transfer (CEST) imaging provides more metabolic information than the changes of tissue microstructure [16]. Amide proton transfer-weighted (APTw) MRI, a subtype of chemical exchange saturation transfer imaging, is a molecular MRI technique that mainly explores the chemical transfer properties of amide protons located at a chemical shift of 3.5 ppm [17]. The APT signal intensity (APT SI) reflects the concentrations of mobile macromolecules, such as proteins and peptides. With the ability to obtain biochemical information, APTw enables the exploration of tissue microenvironment noninvasively, and has gained increasing interest as a valuable adjunct to conventional MRI [18]. Previous studies demonstrated that APTw MRI has been successfully applied to brain tumor [19], breast cancer [20], prostate cancer [21], rectal cancer [22], bladder cancer [23], etc.
APTw and DKI offer the ability for visualizing the microenvironment and microstructural heterogeneity of tumor tissues, reportedly linked to tumor characteristics, thus with the potential for predicting LNM. So far, few studies focused on estimating the presence of LNM. In this study, we aimed to investigate the potential of the combination of APTw MRI with ZOOMit DKI in predicting the pretreatment LNM in CC based on the primary tumors.

2. Materials and Methods

2.1. Patient Population

The ethics committee of our hospital approved this retrospective study, and the requirement for informed consent was waived. From September 2021 to July 2022, a consecutive series of 105 patients suspected of having CC were enrolled in this cohort and underwent pelvic MRI. The inclusion criteria were as follows: (1) no therapy performed prior to the MRI examination and (2) no contraindications to MRI. The exclusion criteria were as follows: (1) no or incomplete histopathological results (n = 21); (2) confirmed non-cervical cancer (n = 9); (3) maximum tumor diameter less than 10 mm (n = 10); and (4) inadequate image quality due to major artifacts (n = 4). Ultimately, a total of 61 patients with pathologically diagnosed CC were included in this study. The mean age of the patients was 51 ± 12 years (range, 28–78 years). Surgery was performed within 14 days of the MRI examination. The flowchart of the patient selection process is shown in Figure 1.

2.2. MR Imaging Protocol

All participants underwent MR on a 3.0-T MRI scanner (Magnetom Skyra, Siemens Healthcare, Erlangen, Germany) with an 18-channel body phased-array coil. All patients were instructed not to urinate for at least 1 h before the MRI examination so that the bladder would be moderately distended during image acquisition. The routine scan sequences including the T1- and T2-weighted imaging were performed.
CEST-MRI was provided by Zhang Yi’s team of Zhejiang University [24]. The middle slice of axial CEST images was located through the maximum cross section of the tumor present on T2WI images. In the CEST saturation module, ten Gaussian saturation pulses were applied with each a duration of 100 ms and a saturation power level of 2.0 micro T. A total of 63 frequency offsets were acquired for the Z-spectrum. The 63 offsets included reference image and saturated scans at 80, 70, 60, 50, 40, 30, 20, 15.625, 10, ±6, ±5, ±4.5, ±4 (2), ±3.75 (2), ±3.5 (6), ±3.25 (2), ±3 (2), ±2.5 (2), ±2 (2), ±1.5, ±1, ±0.75, ±0.5, ±0.25, and 0 ppm, where numbers in parentheses represented the number of repetitions [24,25]. In addition, the gradient echo (GRE) sequence was applied for B0 inhomogeneity correction. The B0 map was calculated as the division of the phase difference between GRE phase images acquired with two different TEs to the TE difference of 4.92 ms. Then, for each pixel, the Z-spectrum is shifted using the B0 previously calculated. Using B0-corrected magnetization transfer ratio asymmetry (MTRasym) at 3.5 ppm offset, the APTw image was computed. The other parameters were as follows: repetition time (TR)/echo time (TE) = 3100/7.1 ms, field of view = 380 × 332 mm2, matrix size = 128 × 128, slice thickness = 4 mm, inter-slice gap = 1 mm, bandwidth = 399 Hz, and acquisition time = 3 min 20 s.
Axial ZOOMit diffusion-weighted images (DWI) with b-values of 0, 500, 1000, 1500, and 2000 s/mm2 were obtained using a single-shot spin-echo echo-planar imaging sequence. The other acquisition parameters for the DWI sequence were TR/TE = 8000/69.5 ms, field of view = 240 × 100 mm2, matrix size = 120 × 120, slice thickness = 4 mm, inter-slice gap = 1 mm, bandwidth = 1666 Hz, and acquisition time = 4 min 30 s.

2.3. Image Analysis

All data were transferred to post-processing software for quantitative analysis. APTw images were analyzed using MATLAB software (The MathWorks, Inc., Natick, MA, USA) based on the original Z-spectral signal [24,25]. The APTw parameter was computed as the MTRasym at 3.5 ppm, which was calculated using the following equation:
MTR asym   ( 3.5   ppm ) =   S sat   ( 3.5   ppm ) / S 0   S sat   ( + 3.5   ppm ) / S 0
where MTRasym (3.5 ppm) is the asymmetric magnetization transfer rate at 3.5 ppm, Ssat represents signal intensity (SI) obtained with applied saturation pulse, and S0 represents SI with unsaturated pulse.
The ZOOMit DWI images were processed using MR Body Diffusion Toolbox v1.5.0 (Siemens Healthcare, Erlangen, Germany). For the DKI model, DKI parameters were calculated using the following equation [26] with five b-values (0, 500, 1000, 1500, and 2000 s/mm2):
S b =   S 0 × exp ( b ×   MD   +   b 2 ×   MD 2 × MK / 6 )
where Sb is the SI at a particular b value, S0 is the SI when b = 0 s/mm2, mean kurtosis (MK) indicates the degree of dispersion deviation from Gaussian distribution, and mean diffusivity (MD) represents the apparent diffusion coefficient (ADC) after non-Gaussian behavior modification.
The MRI images were analyzed by two radiologists (Y.W. and C.F., with 10 and 15 years of experience in pelvic MRI diagnosis, respectively) independently, blinded to the histopathologic findings. The regions of interest (ROIs) were manually delineated along the tumor border on the largest cross-sectional tumor area on APTw images and on DKI maps, using the T2WI as a reference (Figure 2 and Figure 3), while carefully avoiding the areas of necrosis, cystic degeneration, hemorrhage, and blood vessels. The average value of each parameter as measured by the two radiologists was taken for final analysis.

2.4. Statistical Analysis

Statistical analysis was performed using SPSS (version 23.0; IBM Corp., Armonk, N.Y., USA), MedCalc (version 20.0; MedCalc Software Ltd., Ostend, Belgium), and GraphPad Prism (version 9.0; GraphPad Software, San Diego, CA, USA). Intraclass correlation coefficients (ICCs) were used to assess the interobserver agreement of each parameter (<0.4, low consistency; 0.40–0.75, medium consistency; >0.75, high consistency). Kolmogorov–Smirnov test was utilized to estimate the normality of the continuous variables. Continuous variables were expressed as mean ± standard deviation (SD) and were compared between LNM and non-LNM groups with Student’s t-test or Mann–Whitney U test. Categorical variables were expressed as counts and percentages and compared using χ2 test or Fisher’s probability analysis. Binary logistic regression analysis was performed to evaluate the association between the LNM status and the risk factors, and to determine diagnostic efficacy of combined parameters. Receiver operating characteristic curve (ROC) analysis was used to evaluate the diagnostic performance of CEST and DKI parameters for discriminating LNM from non-LNM. Meanwhile, the area under curve (AUC), sensitivity, and specificity were reported by using the Youden index. AUCs of different parameters were compared using the DeLong test. Spearman correlation coefficients were calculated between the metrics and lymph node status. The two-sided p < 0.05 was considered statistically significant.

3. Results

3.1. Participant Characteristics

The clinicopathologic data of the 61 included patients are presented in Table 1. The participants were divided into LNM group (n = 17) and non-LNM group (n = 44), according to the pathological findings. Statistically significant differences in tumor size, FIGO stage, histological grade, and depth of invasion were found between the LNM and non-LNM groups (p = 0.009, p < 0.001, p = 0.009, and p < 0.001, respectively). There were no significant differences in age, menopausal status, histological classification, squamous cell carcinoma antigen (SCC-Ag) level, and vascular invasion between the LNM and non-LNM groups (all p > 0.05).

3.2. Interobserver Reliability Analysis

The interobserver consistency assessment of APTw and DKI-derived parameters shows excellent reproducibility, with ICCs of 0.908 (95% CI: 0.855, 0.943), 0.987 (95% CI: 0.979, 0.992), and 0.984 (95% CI: 0.974, 0.990) for APTw, MK, and MD, respectively.

3.3. Comparisons of APTw, MK, and MD between Different Histopathological Parameters

Comparisons of APTw, MK, and MD between different histopathological parameters are shown in Table 2. The LNM group presented significantly higher APTw (3.7 ± 1.1% vs. 2.4 ± 1.0%, p < 0.001) and MK (1.065 ± 0.185 vs. 0.909 ± 0.189, p = 0.005) and lower MD (0.989 ± 0.195 × 10−3 mm2/s vs. 1.193 ± 0.337 × 10−3 mm2/s, p = 0.035) than the non-LNM group. The comparisons of APTw, MK, and MD between LNM and non-LNM groups are shown in Figure 4. The APTw of the tumor was also significantly higher in advanced-stage cervical cancer (FIGO stage IIB-IV) and deeper invasion (≥2/3 of cervical wall) (p = 0.002 and p = 0.001, respectively). The value of MK was higher in patients with a larger tumor size (≥4 cm), advanced-stage cervical cancer, higher histological grade, and deeper invasion (p = 0.009, p < 0.001, p = 0.016, and p < 0.001, respectively). Furthermore, tumors with a larger tumor size, CSC group, advanced-stage cervical cancer, and deeper invasion presented lower MD values (p = 0.005, p = 0.014, p < 0.001, and p = 0.011, respectively).

3.4. Univariate and Multivariate Logistic Regression Analyses

The univariate and multivariate logistic regression analyses for assessing the indicators of LNM are shown in Table 3. In univariate analysis, the APTw (OR = 3.523, p = 0.001), MK (OR = 1.005, p = 0.011), MD (OR = 0.997, p = 0.029), tumor size (OR = 1.041, p = 0.016), histological grade (OR = 5.687, p = 0.008), and depth of invasion (OR = 23.111, p = 0.003) were significantly correlated with the lymph node status of cervical cancer. There were no significant correlations between the lymph node status and age, menopausal status, histological classification, SCC-Ag level, and vascular invasion. Multivariate logistic analysis revealed that APTw (OR = 3.115, p = 0.039) and depth of invasion (OR = 25.473, p = 0.031) were independent predictors for evaluating the status of LNM in CC. To make the model more readable, a nomogram based on predictive logistic regression model was developed to make the results more intuitive. The nomogram is shown as Figure 5.

3.5. Diagnostic Performance of the APTw, MK, and MD in Predicting Lymph Node Status

The diagnostic performance of APTw and DKI-derived parameters (MK and MD) and their combinations for discriminating LNM from non-LNM are shown in Table 4 and Figure 6. The AUC (0.807) of APTw was higher than that of MK (AUC, 0.715) and that of MD (AUC, 0.675) for discriminating LNM from non-LNM, but the differences were not significant (all p > 0.05). Moreover, the combination of APTw, MK, and MD yielded the highest AUC (0.864), with the corresponding sensitivity of 76.5% and specificity of 88.6%. Significantly higher AUC (0.864) was observed in the combination of APTw, MK, and MD than in MD alone (0.675; p = 0.010) for differentiating the lymph node status.

4. Discussion

Our results demonstrated that APTw outperformed the ZOOMit DKI parameters MK and MD in predicting the LNM of CC, and the diagnostic performance could be further improved by the combination of APTw, MK, and MD. With these results, our study indicated that the combination of APTw and ZOOMit DKI could be used as a potential non-invasive biomarker to predict the LNM of CC
The DKI model reflects the non-Gaussian diffusion property caused by the microstructural complexity of tissues and therefore has the potential in quantifying the microstructural heterogeneity of tissues [11,12]. The DKI parameter MK is reported to positively correlate with the heterogeneity of tissue microstructure, while MD represents how freely water can diffuse through a tissue, with lower MD indicating impaired diffusion and probably denser tissue [27]. In this study, CC with higher tumor grade and advanced FIGO stage presented significantly higher MK and lower MD. It is presumed that tumors with higher heterogeneity are more prone to lymph node metastasis, suggesting that DKI parameters may be useful in predicting the LNM based on the primary tumors. Due to the difficulty of matching the lymph nodes on images to the pathologic findings [28], our study attempted to investigate the lymph node status based on the primary tumors, rather than analyzing the lymph nodes directly. Our finding demonstrated that LNM group showed significantly higher MK value and lower MD value than non-LNM group. A similar result was also reported by Yamada et al. [14,29], suggesting that the tumors with LNM had more complex tissue microstructures, which can further limit the diffusion of water molecules [30].
With the ability to detect the exchange of the amide protons in protein or polypeptide with hydrogen protons in water [17], APTw imaging has been successfully applied to characterize rectal cancers [15], bladder tumors [23], endometrial carcinomas [17], and cervical cancers [30]. In this study, higher APTw values were found in CC with higher FIGO stage and deeper tumor invasion, further indicating the possible feasibility of APTw in characterizing cervical cancers. Furthermore, this study indicated that the tumors with LNM presented higher APTw values than the tumors with non-LNM. A similar result was also previously reported in rectal adenocarcinoma by Chen et al. [15]. The possible reason may be that higher levels of proliferation require enhanced protein synthesis, resulting in accumulation of intra-cellular proteins. Hence, higher mobile protein and peptide concentrations of tumor in LNM group might be the main reason for higher APTw in CC. Furthermore, Meng et al. [30,31] demonstrated that APTw value of high grade CC was significantly higher than that of low grade CC, and a similar finding was also reported in bladder cancer [23]. However, a significant difference was not observed between the low grade and high grade CC in this study. The reason may be that only the patients with CSC were included in previous studies [27,32,33], while in this study, the patients with CA were not excluded. CA originates from endocervical cells and therefore has rich glandular structure and the ability to secrete mucin. Due to the different cell origins, APTw values between CSC and CA could be quite different, which may result in inconsistencies with the results of previous studies.
In this study, the APTw, MK, MD, tumor size, histological grade, and depth of invasion were significantly correlated with the lymph node status of CC in univariate analysis. The CC with LNM exhibits more aggressive biological behavior, which is most likely present with larger tumor size, high cellular density, rapid cell proliferation, and enhanced metabolism [34]. The APTw was an independent predictor for LNM of CC in multivariable analysis, suggesting the potential role of APTw in predicting the LNM of CC.
Our results demonstrated that the AUC of APTw (0.807) was higher than those of MK (0.715) and MD (0.675) in differentiating LNM from non-LNM, suggesting the advantage of APTw over the DKI parameters in predicting the LNM of CC. The possible reason may be that the DKI parameters were derived based on the high b-value (2000 s/mm2) DWI, which is more susceptible to the effects of low signal-to-noise ratio and image distortion, possibly resulting in measurement bias [35]. The diagnostic performance of the combination of APTw and DKI parameters for predicting the LNM of CC was also assessed in this study, attempting to explore the changes of metabolic information and the heterogeneity of tumor microstructure simultaneously. The combination of APTw, MK, and MD yielded the highest AUC (0.864) in discriminating LNM from non-LNM, indicating the added value of APTw to DKI in predicting LNM of CC based on the primary tumors.
There are some limitations in this study. First, the sample size of our study was relatively small, resulting in insufficient detection of statistical significance for some variables, such as tumor grade. Second, this study was a single-center study, and it has potential selection bias. Third, only single-slice two-dimensional images of APTw MRI were obtained, rather than three-dimensional images, thus it was impossible to extract the information of the whole tumors.

5. Conclusions

In conclusion, both APTw and ZOOMit DKI parameters have the potential to predict LNM of CC, and the diagnostic performance is further improved by combining both parameters. The APTw and ZOOMit DKI could be used as promising non-invasive tools to predict the LNM of CC, thus aiding in tailoring treatment modality for patients with CC.

Author Contributions

Conceptualization, Y.S., X.H., C.F., Z.L. and I.K.; methodology, C.F., Q.H. and Y.W.; data curation, Q.H.; formal analysis, J.L., Q.H. and X.M.; supervision, Z.L.; project administration, C.F.; writing—original draft preparation, Q.H.; writing—review and editing, C.F. and I.K.; funding acquisition, Z.L., Y.S., Y.W. and J.L. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by grants from the National Natural Science Foundation of China (NSFC) (No. 82071889, 82071890, and 82102025) and the National Science Fund for Distinguished Young Scholars (No.82202127).

Institutional Review Board Statement

This retrospective study was approved by our Institutional Ethics Review Board.

Informed Consent Statement

Patient consent was waived due to some patients with cervical cancer died and lost follow-up.

Data Availability Statement

The datasets generated or analyzed during the study are available from the corresponding author upon reasonable request.

Acknowledgments

The authors acknowledge Qiuxia Wang for assisting in patient scans. The authors thank Siemens Healthcare for support for this study.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 68, 394–424. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Olawaiye, A.B.; Baker, T.P.; Washington, M.K.; Mutch, D.G. The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer. CA Cancer J. Clin. 2021, 71, 287–298. [Google Scholar] [CrossRef] [PubMed]
  3. Koh, W.J.; Abu-Rustum, N.R.; Bean, S.; Bradley, K.; Campos, S.M.; Cho, K.R.; Chon, H.S.; Chu, C.; Clark, R.; Cohn, D.; et al. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Cancer Netw. 2019, 17, 64–84. [Google Scholar] [CrossRef] [Green Version]
  4. Landoni, F.; Maneo, A.; Colombo, A.; Placa, F.; Milani, R.; Perego, P.; Favini, G.; Ferri, L.; Mangioni, C. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997, 350, 535–540. [Google Scholar] [CrossRef] [PubMed]
  5. Haldorsen, I.S.; Lura, N.; Blaakær, J.; Fischerova, D.; Werner, H.M.J. What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer? Curr. Oncol. Rep. 2019, 21, 77. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Woo, S.; Atun, R.; Ward, Z.J.; Scott, A.M.; Hricak, H.; Vargas, H.A. Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: Systematic review and meta-analysis. Eur. Radiol. 2020, 30, 5560–5577. [Google Scholar] [CrossRef]
  7. Xiao, M.; Yan, B.; Li, Y.; Lu, J.; Qiang, J. Diagnostic performance of MR imaging in evaluating prognostic factors in patients with cervical cancer: A meta-analysis. Eur. Radiol. 2020, 30, 1405–1418. [Google Scholar] [CrossRef]
  8. Chen, M.; Feng, C.; Wang, Q.; Li, J.; Wu, S.; Hu, D.; Deng, B.; Li, Z. Comparison of reduced field-of-view diffusion-weighted imaging (DWI) and conventional DWI techniques in the assessment of Cervical carcinoma at 3.0 T: Image quality and FIGO staging. Eur. J. Radiol. 2021, 137, 109557. [Google Scholar] [CrossRef]
  9. Li, S.; He, K.; Yuan, G.; Yong, X.; Meng, X.; Feng, C.; Zhang, Y.; Kamel, I.R.; Li, Z. WHO/ISUP grade and pathological T stage of clear cell renal cell carcinoma: Value of ZOOMit diffusion kurtosis imaging and chemical exchange saturation transfer imaging. Eur. Radiol. 2022. [Google Scholar] [CrossRef]
  10. Lin, G.; Ho, K.C.; Wang, J.J.; Ng, K.K.; Wai, Y.Y.; Chen, Y.T.; Chang, C.J.; Ng, S.H.; Lai, C.H.; Yen, T.C. Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3 T. J. Magn. Reson. Imaging 2008, 28, 128–135. [Google Scholar] [CrossRef]
  11. Jensen, J.H.; Helpern, J.A.; Ramani, A.; Lu, H.; Kaczynski, K. Diffusional kurtosis imaging: The quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn. Reson. Med. 2005, 53, 1432–1440. [Google Scholar] [CrossRef]
  12. Jensen, J.H.; Helpern, J.A. MRI quantification of non-Gaussian water diffusion by kurtosis analysis. NMR Biomed. 2010, 23, 698–710. [Google Scholar] [CrossRef] [Green Version]
  13. Li, Q.; Cao, B.; Tan, Q.; Liu, K.; Jiang, S.; Zhou, J. Prediction of muscle invasion of bladder cancer: A comparison between DKI and conventional DWI. Eur. J. Radiol. 2021, 136, 109522. [Google Scholar] [CrossRef]
  14. Yamada, I.; Oshima, N.; Wakana, K.; Miyasaka, N.; Wakabayashi, A.; Sakamoto, J.; Saida, Y.; Tateishi, U.; Kobayashi, D. Uterine Cervical Carcinoma: Evaluation Using Non-Gaussian Diffusion Kurtosis Imaging and Its Correlation with Histopathological Findings. J. Comput. Assist. Tomogr. 2021, 45, 29–36. [Google Scholar] [CrossRef] [PubMed]
  15. Chen, W.; Li, L.; Yan, Z.; Hu, S.; Feng, J.; Liu, G.; Liu, B.; Liu, X. Three-dimension amide proton transfer MRI of rectal adenocarcinoma: Correlation with pathologic prognostic factors and comparison with diffusion kurtosis imaging. Eur. Radiol. 2021, 31, 3286–3296. [Google Scholar] [CrossRef] [PubMed]
  16. Dou, W.; Lin, C.E.; Ding, H.; Shen, Y.; Dou, C.; Qian, L.; Wen, B.; Wu, B. Chemical exchange saturation transfer magnetic resonance imaging and its main and potential applications in pre-clinical and clinical studies. Quant. Imaging Med. Surg. 2019, 9, 1747–1766. [Google Scholar] [CrossRef] [PubMed]
  17. Takayama, Y.; Nishie, A.; Togao, O.; Asayama, Y.; Ishigami, K.; Ushijima, Y.; Okamoto, D.; Fujita, N.; Sonoda, K.; Hida, T.; et al. Amide Proton Transfer MR Imaging of Endometrioid Endometrial Adenocarcinoma: Association with Histologic Grade. Radiology 2018, 286, 909–917. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. He, Y.L.; Li, Y.; Lin, C.Y.; Qi, Y.F.; Wang, X.; Zhou, H.L.; Yang, J.J.; Xiang, Y.; Xue, H.D.; Jin, Z.Y. Three-dimensional turbo-spin-echo amide proton transfer-weighted mri for cervical cancer: A preliminary study. J. Magn. Reson. Imaging 2019, 50, 1318–1325. [Google Scholar] [CrossRef]
  19. Park, J.E.; Kim, H.S.; Park, S.Y.; Jung, S.C.; Kim, J.H.; Heo, H.Y. Identification of Early Response to Anti-Angiogenic Therapy in Recurrent Glioblastoma: Amide Proton Transfer-weighted and Perfusion-weighted MRI compared with Diffusion-weighted MRI. Radiology 2020, 295, 397–406. [Google Scholar] [CrossRef]
  20. Meng, N.; Wang, X.; Sun, J.; Han, D.; Bai, Y.; Wei, W.; Wang, Z.; Jia, F.; Wang, K.; Wang, M. A comparative study of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in the diagnosis and evaluation of breast cancer. Eur. Radiol. 2021, 31, 1707–1717. [Google Scholar] [CrossRef]
  21. Jia, G.; Abaza, R.; Williams, J.D.; Zynger, D.L.; Zhou, J.; Shah, Z.K.; Patel, M.; Sammet, S.; Wei, L.; Bahnson, R.R.; et al. Amide proton transfer MR imaging of prostate cancer: A preliminary study. J. Magn. Reson. Imaging 2011, 33, 647–654. [Google Scholar] [CrossRef] [Green Version]
  22. Nishie, A.; Takayama, Y.; Asayama, Y.; Ishigami, K.; Ushijima, Y.; Okamoto, D.; Fujita, N.; Tsurumaru, D.; Togao, O.; Manabe, T.; et al. Amide proton transfer imaging can predict tumor grade in rectal cancer. Magn. Reson. Imaging 2018, 51, 96–103. [Google Scholar] [CrossRef]
  23. Wang, H.J.; Cai, Q.; Huang, Y.P.; Li, M.Q.; Wen, Z.H.; Lin, Y.Y.; Ouyang, L.Y.; Qian, L.; Guo, Y. Amide Proton Transfer-weighted MRI in Predicting Histologic Grade of Bladder Cancer. Radiology 2022, 305, 127–134. [Google Scholar] [CrossRef] [PubMed]
  24. Liu, R.; Zhang, H.; Qian, Y.; Hsu, Y.C.; Fu, C.; Sun, Y.; Wu, D.; Zhang, Y. Frequency-stabilized chemical exchange saturation transfer imaging with real-time free-induction-decay readout. Magn. Reson. Med. 2021, 85, 1322–1334. [Google Scholar] [CrossRef]
  25. Liu, R.; Zhang, H.; Niu, W.; Lai, C.; Ding, Q.; Chen, W.; Liang, S.; Zhou, J.; Wu, D.; Zhang, Y. Improved chemical exchange saturation transfer imaging with real-time frequency drift correction. Magn. Reson. Med. 2019, 81, 2915–2923. [Google Scholar] [CrossRef]
  26. Minosse, S.; Marzi, S.; Piludu, F.; Vidiri, A. Correlation study between DKI and conventional DWI in brain and head and neck tumors. Magn. Reson. Imaging 2017, 42, 114–122. [Google Scholar] [CrossRef]
  27. Hou, M.; Song, K.; Ren, J.; Wang, K.; Guo, J.; Niu, Y.; Li, Z.; Han, D. Comparative analysis of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in evaluating the histological grade of cervical squamous carcinoma. BMC Cancer 2022, 22, 87. [Google Scholar] [CrossRef]
  28. Nakai, G.; Matsuki, M.; Inada, Y.; Tatsugami, F.; Tanikake, M.; Narabayashi, I.; Yamada, T. Detection and evaluation of pelvic lymph nodes in patients with gynecologic malignancies using body diffusion-weighted magnetic resonance imaging. J. Comput. Assist. Tomogr. 2008, 32, 764–768. [Google Scholar] [CrossRef] [PubMed]
  29. Yamada, I.; Sakamoto, J.; Kobayashi, D.; Miyasaka, N.; Wakana, K.; Oshima, N.; Wakabayashi, A.; Saida, Y.; Tateishi, U.; Eishi, Y. Diffusion kurtosis imaging of endometrial carcinoma: Correlation with histopathological findings. Magn. Reson. Imaging 2019, 57, 337–346. [Google Scholar] [CrossRef] [PubMed]
  30. Meng, N.; Wang, X.; Sun, J.; Han, D.; Ma, X.; Wang, K.; Wang, M. Application of the amide proton transfer-weighted imaging and diffusion kurtosis imaging in the study of cervical cancer. Eur. Radiol. 2020, 30, 5758–5767. [Google Scholar] [CrossRef]
  31. Meng, N.; Wang, X.; Sun, J.; Huang, Z.; Yang, Z.; Shang, J.; Bai, Y.; Wei, W.; Han, D.; Han, H.; et al. Evaluation of amide proton transfer-weighted imaging for endometrial carcinoma histological features: A comparative study with diffusion kurtosis imaging. Eur. Radiol. 2021, 31, 8388–8398. [Google Scholar] [CrossRef] [PubMed]
  32. Meng, X.; Tian, S.; Ma, C.; Lin, L.; Zhang, X.; Wang, J.; Song, Q.; Liu, A.L. APTw combined with mDixon-Quant imaging to distinguish the differentiation degree of cervical squamous carcinoma. Front. Oncol. 2023, 13, 1105867. [Google Scholar] [CrossRef] [PubMed]
  33. Li, B.; Sun, H.; Zhang, S.; Wang, X.; Guo, Q. Amide proton transfer imaging to evaluate the grading of squamous cell carcinoma of the cervix: A comparative study using (18) F FDG PET. J. Magn. Reson. Imaging 2019, 50, 261–268. [Google Scholar] [CrossRef] [PubMed]
  34. Li, B.; Sun, H.; Zhang, S.; Wang, X.; Guo, Q. The utility of APT and IVIM in the diagnosis and differentiation of squamous cell carcinoma of the cervix: A pilot study. Magn. Reson. Imaging 2019, 63, 105–113. [Google Scholar] [CrossRef]
  35. Van Cauter, S.; Veraart, J.; Sijbers, J.; Peeters, R.R.; Himmelreich, U.; De Keyzer, F.; Van Gool, S.W.; Van Calenbergh, F.; De Vleeschouwer, S.; Van Hecke, W.; et al. Gliomas: Diffusion kurtosis MR imaging in grading. Radiology 2012, 263, 492–501. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Flow chart of patient enrollment.
Figure 1. Flow chart of patient enrollment.
Bioengineering 10 00331 g001
Figure 2. MRI scans in a 64−year−old woman with cervical cancer and postoperative pathology revealed LNM. Axial (A) T2−weighted image illustrates an exophytic tumor on the cervix wall. A diffusion−weighted image (B) with b = 1000 s/mm2 shows a high−signal−intensity tumor. Mean kurtosis (MK) map (C) and mean diffusivity (MD) map (D) generated from DKI model. Amide proton transfer−weighted (APTw) image (E) and Z−spectrum of the tumor (F); the color bar indicates the APTw value. The mean MK, MD, and APTw values measured by the two radiologists were 1.116, 0.774 × 10−3 mm2/s, and 4.5%, respectively.
Figure 2. MRI scans in a 64−year−old woman with cervical cancer and postoperative pathology revealed LNM. Axial (A) T2−weighted image illustrates an exophytic tumor on the cervix wall. A diffusion−weighted image (B) with b = 1000 s/mm2 shows a high−signal−intensity tumor. Mean kurtosis (MK) map (C) and mean diffusivity (MD) map (D) generated from DKI model. Amide proton transfer−weighted (APTw) image (E) and Z−spectrum of the tumor (F); the color bar indicates the APTw value. The mean MK, MD, and APTw values measured by the two radiologists were 1.116, 0.774 × 10−3 mm2/s, and 4.5%, respectively.
Bioengineering 10 00331 g002
Figure 3. MRI scans in a 25−year−old woman with cervical cancer and postoperative pathology revealed non−LNM. Axial (A) T2−weighted image illustrates an exophytic tumor on the cervix wall. A diffusion−weighted image (B) with b = 1000 s/mm2 shows a high−signal−intensity tumor. Mean kurtosis (MK) map (C) and mean diffusivity (MD) map (D) generated from DKI model. Amide proton transfer−weighted (APTw) image (E) and Z−spectrum of the tumor (F); the color bar indicates the APTw value. The mean MK, MD, and APTw values measured by the two radiologists were 0.832, 1.123 × 10−3 mm2/s, and 1.7%, respectively.
Figure 3. MRI scans in a 25−year−old woman with cervical cancer and postoperative pathology revealed non−LNM. Axial (A) T2−weighted image illustrates an exophytic tumor on the cervix wall. A diffusion−weighted image (B) with b = 1000 s/mm2 shows a high−signal−intensity tumor. Mean kurtosis (MK) map (C) and mean diffusivity (MD) map (D) generated from DKI model. Amide proton transfer−weighted (APTw) image (E) and Z−spectrum of the tumor (F); the color bar indicates the APTw value. The mean MK, MD, and APTw values measured by the two radiologists were 0.832, 1.123 × 10−3 mm2/s, and 1.7%, respectively.
Bioengineering 10 00331 g003
Figure 4. The scatter plots of (A) amide proton transfer-weighted (APTw), (B) mean kurtosis (MK), and (C) mean diffusivity (MD) values between LNM and non-LNM groups in cervical cancer. There were significant differences in APTw, MK, and MD values between LNM group and non-LNM group (* p < 0.05; ** p < 0.01; *** p < 0.001).
Figure 4. The scatter plots of (A) amide proton transfer-weighted (APTw), (B) mean kurtosis (MK), and (C) mean diffusivity (MD) values between LNM and non-LNM groups in cervical cancer. There were significant differences in APTw, MK, and MD values between LNM group and non-LNM group (* p < 0.05; ** p < 0.01; *** p < 0.001).
Bioengineering 10 00331 g004
Figure 5. According to the logistic regression model, the nomogram was obtained. The probability of LNM was calculated by substituting various factors into the nomogram.
Figure 5. According to the logistic regression model, the nomogram was obtained. The probability of LNM was calculated by substituting various factors into the nomogram.
Bioengineering 10 00331 g005
Figure 6. Receiver operating characteristic curves (ROC) analysis of each parameter for predicting the LNM in patients with cervical cancer. The area under curves (AUCs) of amide proton transfer-weighted (APTw), mean kurtosis (MK), mean diffusivity (MD) values, and combination model (APTw + MK + MD) to evaluate LNM status were 0.807 (95% CI: 0.686–0.897), 0.715 (95% CI: 0.585–0.823), 0.675 (95% CI: 0.543–0.790), and 0.864 (95% CI: 0.752–0.938), respectively. The combination of APTw, MK, and MD yielded the highest AUC.
Figure 6. Receiver operating characteristic curves (ROC) analysis of each parameter for predicting the LNM in patients with cervical cancer. The area under curves (AUCs) of amide proton transfer-weighted (APTw), mean kurtosis (MK), mean diffusivity (MD) values, and combination model (APTw + MK + MD) to evaluate LNM status were 0.807 (95% CI: 0.686–0.897), 0.715 (95% CI: 0.585–0.823), 0.675 (95% CI: 0.543–0.790), and 0.864 (95% CI: 0.752–0.938), respectively. The combination of APTw, MK, and MD yielded the highest AUC.
Bioengineering 10 00331 g006
Table 1. Clinicopathological characteristics and lymph node status of patients with cervical cancer.
Table 1. Clinicopathological characteristics and lymph node status of patients with cervical cancer.
CharacteristicsTotalNon-LNMLNMp
No. of Patients614417
Age (years) a51 ± 12 (28–78)50 ± 12 (28–78)52 ± 12 (29–70)0.513
Tumor size (mm) a36 ± 21 (13–105)31 ± 17 (15–72)44 ± 19 (13–105)0.009
Menopausal status 0.437 *
No30 (49.2)23 (52.3)7 (41.2)
Yes31 (50.8)21 (47.7)10 (58.8)
Histological classification 0.423 *
CSC52 (85.2)36 (81.8)16 (94.1)
CA9 (14.8)8 (18.2)1 (5.9)
FIGO stage <0.001 *
Early stage (IB-IIA)32 (52.5)31 (70.5)1 (5.9)
Advanced stage (IIB-IV)29 (47.5)13 (29.5)16 (94.1)
Histologic grade 0.009 *
Low grade32 (52.5)28 (63.6)4 (23.5)
High grade29 (47.5)16 (36.4)13 (76.5)
Depth of invasion <0.001 *
<2/3 of cervical wall27 (44.3)26 (59.1)1 (5.9)
≥2/3 of cervical wall34 (55.7)18 (40.9)16 (94.1)
SCC-Ag level 0.133 *
≤1.5 ng/mL21 (34.4)18 (40.9)3 (17.6)
>1.5 ng/mL40 (65.6)26 (59.1)14 (82.4)
Vascular invasion 0.421 *
No44 (72.1)33 (75.0)11 (64.7)
Yes17 (27.9)11 (25.0)6 (35.3)
a Numbers are means ± standard deviations with ranges in parentheses; other data are presented as n (%). * Chi-square test used. The bold font in the table indicates the comparison with statistical significance. LNM = lymph node metastasis; Non-LNM = non-lymph node metastasis; CSC = cervical squamous carcinoma; CA = cervical adenocarcinoma; FIGO = International Federation of Gynecology and Obstetrics; SCC-Ag = squamous cell carcinoma antigen.
Table 2. Comparison of APTw and DKI-derived parameters among different histopathological parameters of cervical cancer.
Table 2. Comparison of APTw and DKI-derived parameters among different histopathological parameters of cervical cancer.
VariablesAPTw (%)pMKpMD (×10−3 mm2/s)p
Lymph node status <0.001 0.005 0.035 *
Non-LNM (n = 44)2.4 ± 1.0 0.909 ± 0.189 1.193 ± 0.337
LNM (n = 17)3.7 ± 1.1 1.065 ± 0.185 0.989 ± 0.195
Tumor size 0.319 0.009 0.005 *
<4 cm (n = 39)2.6 ± 1.2 0.903 ± 0.191 1.219 ± 0.336
≥4 cm (n = 22)3.0 ± 1.1 1.040 ± 0.187 0.990 ± 0.213
Histological classification 0.447 0.471 0.014 *
CSC (n = 52)2.8 ± 1.2 0.960 ± 0.191 1.076 ± 0.230
CA (n = 9)2.5 ± 1.2 0.908 ± 0.247 1.485 ± 0.501
FIGO stage 0.002 <0.001 <0.001 *
Early-stage (n = 32)2.3 ± 1.0 0.857 ± 0.186 1.285 ± 0.345
Advanced-stage (n = 29)3.2 ± 1.1 1.058 ± 0.157 0.973 ± 0.171
Histological grade 0.117 0.016 0.142 *
Low grade (n = 32)2.5 ± 1.0 0.895 ± 0.195 1.193 ± 0.371
High grade (n = 29)3.0 ± 1.2 1.016 ± 0.187 1.074 ± 0.232
Depth of invasion 0.001 <0.001 0.011 *
<2/3 of cervical wall
(n = 27)
2.2 ± 0.9 0.845 ± 0.175 1.270 ± 0.381
≥2/3 of cervical wall
(n = 34)
3.2 ± 1.2 1.038 ± 0.176 1.031 ± 0.202
Vascular invasion 0.140 0.210 0.394 *
No (n = 44)2.6 ± 1.0 0.933 ± 0.215 1.132 ± 0.345
Yes (n = 17)3.1 ± 1.4 1.004 ± 0.142 1.148 ± 0.234
* Mann–Whitney U test; others are Students’ t-test. Bold type face in the table indicates that the comparison is statistically significant. APTw = amide proton transfer-weighted; MK = mean kurtosis; MD = mean diffusivity; LNM= lymph node metastasis; Non-LNM = non-lymph node metastasis; CSC = cervical squamous carcinoma; CA = cervical adenocarcinoma; FIGO = International Federation of Gynecology and Obstetrics.
Table 3. Univariate and multivariate logistic regression analysis for LNM in cervical cancer.
Table 3. Univariate and multivariate logistic regression analysis for LNM in cervical cancer.
VariableUnivariate AnalysisMultivariate Analysis
Odds Ratio (95 % CI)pOdds Ratio (95 % CI)p
APTw (%)3.523 (1.676, 7.404)0.0013.115 (1.059, 9.162)0.039
MK1.005 (1.001, 1.008)0.0111.000 (0.991, 1.008)0.911
MD (×10−3 mm2/s)0.997 (0.994, 1.000)0.0290.998 (0.990, 1.005)0.503
Age1.017 (0.968, 1.068)0.507
Tumor size1.041 (1.008, 1.075)0.0160.949 (0.878, 1.025)0.184
Menopausal status1.565 (0.504, 4.856)0.439
Histological classification0.281 (0.032, 2.440)0.250
Histologic grade5.687 (1.585, 20.414)0.0081.628 (0.207, 12.781)0.643
Depth of invasion23.111 (2.808, 190.202)0.00325.473 (1.351, 480.376)0.031
SCC-Ag level3.231 (0.809, 12.896)0.097
Vascular invasion1.636 (0.490, 5.467)0.424
All factors with p < 0.05 in univariate analysis were included in multivariate regression analysis. The bold typeface in the table indicates the logistic regression analysis with statistical significance. CI = confidence interval; LNM = lymph node metastasis; APTw = amide proton transfer-weighted; MK = mean kurtosis; MD = mean diffusivity; SCC-Ag = squamous cell carcinoma antigen.
Table 4. Diagnostic performance of APTw, MK, and MD values in predicting LNM in cervical cancer.
Table 4. Diagnostic performance of APTw, MK, and MD values in predicting LNM in cervical cancer.
ParametersCutoffAUC
(95% CI)
Sensitivity
(%)
Specificity
(%)
pp for Comparison
APTw (%)2.8560.807 (0.686–0.897)82.470.5<0.0010.132
MK0.9320.715 (0.585–0.823)88.252.30.0020.053
MD (×10−3 mm2/s)1.1710.675 (0.543–0.790)88.243.20.0170.010
Combination-0.864 (0.752–0.938)76.588.6<0.001Ref
Combination represents APTw + MK + MD. The bold typeface in the table indicates significant difference compared with the Ref by DeLong test. APTw = amide proton transfer-weighted; MK = mean kurtosis; MD = mean diffusivity; LNM = lymph node metastasis; CC = cervical cancer; AUC = area under the curve; Ref = reference.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Huang, Q.; Wang, Y.; Meng, X.; Li, J.; Shen, Y.; Hu, X.; Feng, C.; Li, Z.; Kamel, I. Amide Proton Transfer-Weighted Imaging Combined with ZOOMit Diffusion Kurtosis Imaging in Predicting Lymph Node Metastasis of Cervical Cancer. Bioengineering 2023, 10, 331. https://doi.org/10.3390/bioengineering10030331

AMA Style

Huang Q, Wang Y, Meng X, Li J, Shen Y, Hu X, Feng C, Li Z, Kamel I. Amide Proton Transfer-Weighted Imaging Combined with ZOOMit Diffusion Kurtosis Imaging in Predicting Lymph Node Metastasis of Cervical Cancer. Bioengineering. 2023; 10(3):331. https://doi.org/10.3390/bioengineering10030331

Chicago/Turabian Style

Huang, Qiuhan, Yanchun Wang, Xiaoyan Meng, Jiali Li, Yaqi Shen, Xuemei Hu, Cui Feng, Zhen Li, and Ihab Kamel. 2023. "Amide Proton Transfer-Weighted Imaging Combined with ZOOMit Diffusion Kurtosis Imaging in Predicting Lymph Node Metastasis of Cervical Cancer" Bioengineering 10, no. 3: 331. https://doi.org/10.3390/bioengineering10030331

APA Style

Huang, Q., Wang, Y., Meng, X., Li, J., Shen, Y., Hu, X., Feng, C., Li, Z., & Kamel, I. (2023). Amide Proton Transfer-Weighted Imaging Combined with ZOOMit Diffusion Kurtosis Imaging in Predicting Lymph Node Metastasis of Cervical Cancer. Bioengineering, 10(3), 331. https://doi.org/10.3390/bioengineering10030331

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop